Chi-Ping Day

Title: Innovations by Chi-Ping Day in Cancer Research

Introduction

Chi-Ping Day is an accomplished inventor based in Houston, TX (US). He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of 2 patents, his work focuses on developing cancer-specific control sequences that enhance therapeutic gene expression.

Latest Patents

Chi-Ping Day's latest patents revolve around cancer-specific promoters. These inventions direct the expression of polynucleotides encoding therapeutic gene products aimed at treating various types of cancer. Specifically, his patents encompass control sequences tailored for breast cancer, prostate cancer, and pancreatic cancer. Two of the breast cancer-specific sequences utilize regions of topoisomerase IIα and transferrin receptor promoters, particularly in combination with an enhancer. The prostate cancer-specific and pancreatic cancer-specific control sequences employ composites of tissue-specific control sequences, a two-step transcription amplification sequence, and a post-transcriptional control sequence. In particular embodiments, these polynucleotides are administered alongside liposomes to enhance their efficacy.

Career Highlights

Chi-Ping Day is affiliated with the University of Texas System, where he continues to advance his research in cancer therapeutics. His innovative work has positioned him as a key figure in the development of targeted cancer treatments.

Collaborations

Some of his notable coworkers include Mien-Chie Hung and Kun-Ming Rau, who have collaborated with him on various research projects.

Conclusion

Chi-Ping Day's contributions to cancer research through his innovative patents highlight the importance of targeted therapies in the fight against cancer. His work continues to pave the way for advancements in therapeutic strategies.